Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04186429 · ClinicalTrials.gov registry record
Epigenetic Effects on Traumatic Brain Injury Recovery
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 401
- Enrollment target
NCT04186429: Completed study, sponsored by University of Pittsburgh.
NCT04186429 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 401 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04186429 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 401 participants
- Enrollment target
Study Summary
Methylation of the brain-derived neurotrophic factor (BDNF) gene is involved in both the biological encoding of childhood adversity and neuroplasticity following traumatic brain injury (TBI). This research will characterize BDNF methylation during recovery from TBI in children and investigate this novel biomarker as a potential biological mechanism underlying the known association between childhood adversity and poorer neurobehavioral outcomes following TBI in childhood. Findings from this research will contribute to an improved understanding of why some children display good recovery following TBI, whereas many others suffer from chronic neurobehavioral impairments.
Primary Outcome
The NIHTB-CB is a 30-minute battery of standardized neuropsychological tests administered on an iPad. The NIHTB-CB provides norm-referenced scores for the domains of language, episodic memory, processing speed, working memory, and executive function, as well as an overall cognitive function composite score. Higher T scores indicate better neuropsychological performance.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 401 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2024-08-31 |
What the finished NCT04186429 record still lists
NCT04186429 is an observational study that tracks outcomes without assigning an intervention. The registered 401 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04186429 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04186429 about?
NCT04186429 is a clinical study titled "Epigenetic Effects on Traumatic Brain Injury Recovery". Methylation of the brain-derived neurotrophic factor (BDNF) gene is involved in both the biological encoding of childhood adversity and neuroplasticity following traumatic brain injury (TBI). This research will characterize BDNF methylation during recovery from TBI in children and investigate this n...
What is the current status of trial NCT04186429?
This trial is currently completed. The enrollment target is 401 participants. The study started on 2017-07-01. Estimated completion is 2024-08-31.
Who is sponsoring clinical trial NCT04186429?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04464226 · 402 participants · Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
- NCT05183763 · 402 participants · NA
Medication Adherence Program
- NCT06748222 · 402 participants · Phase 3
E-Mindfulness Approaches for Living After Breast Cancer
- NCT06896474 · 402 participants · NA
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI